These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38191958)

  • 1. Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer.
    Aizawa R; Inokuchi H; Ikeda I; Nakamura K; Ogata T; Akamatsu S; Goto T; Masui K; Sumiyoshi T; Kita Y; Kobayashi T; Mizowaki T
    Int J Clin Oncol; 2024 Mar; 29(3):325-332. PubMed ID: 38191958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
    Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
    Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.
    Li M; Li GF; Hou XY; Gao H; Xu YG; Zhao T
    Chin Med J (Engl); 2016 Jun; 129(12):1447-54. PubMed ID: 27270540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose escalated fiducial marker-based image guided radical radiotherapy in locally advanced prostate cancers: A single institute experience from India.
    Gupta PK; Rastogi N; Maria Das KJ; Kumar S
    J Cancer Res Ther; 2023; 19(2):382-388. PubMed ID: 37006073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
    Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram to predict rectal toxicity following prostate cancer radiotherapy.
    Delobel JB; Gnep K; Ospina JD; Beckendorf V; Chira C; Zhu J; Bossi A; Messai T; Acosta O; Castelli J; de Crevoisier R
    PLoS One; 2017; 12(6):e0179845. PubMed ID: 28640871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
    Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA
    Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.
    Marina O; Gustafson GS; Kestin LL; Brabbins DS; Chen PY; Ye H; Martinez AA; Ghilezan MI; Wallace M; Krauss DJ
    Brachytherapy; 2014; 13(1):59-67. PubMed ID: 23871661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Clinical Results of IGRT in Prostate Cancer Treatment.
    Doležel M; Odrážka K; Vaňásek J; Štuk J; Hlávka A; Vítková M; Ulrych V; Kohlová T; Vlachová Z; Hafuda A; Hartmann I
    Klin Onkol; 2020; 33(1):49-54. PubMed ID: 32075389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.
    Zapatero A; Roch M; Büchser D; Castro P; Fernández-Banda L; Pozo G; Liñán O; Martin de Vidales C; Cruz-Conde A; García-Vicente F
    Clin Transl Oncol; 2017 Sep; 19(9):1161-1167. PubMed ID: 28374321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental changes verses a technological quantum leap: the additional value of intensity-modulated radiotherapy beyond image-guided radiotherapy for prostate irradiation.
    Ratnayake G; Martin J; Plank A; Wong W
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):503-10. PubMed ID: 25243269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy.
    Sasaki N; Yamazaki H; Shimizu D; Suzuki G; Masui K; Nakamura S; Okabe H; Nishikawa T; Yoshida K
    Anticancer Res; 2018 Jan; 38(1):385-391. PubMed ID: 29277799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
    Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
    Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
    Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of image guidance to clinical outcomes for localized prostate cancer.
    Zhong Q; Gao H; Li G; Xiu X; Wu Q; Li M; Xu Y
    Biomed Res Int; 2014; 2014():860639. PubMed ID: 25110701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.
    Tamihardja J; Schortmann M; Lawrenz I; Weick S; Bratengeier K; Flentje M; Guckenberger M; Polat B
    Strahlenther Onkol; 2021 Feb; 197(2):124-132. PubMed ID: 32833036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
    Murray J; Griffin C; Gulliford S; Syndikus I; Staffurth J; Panades M; Scrase C; Parker C; Khoo V; Dean J; Mayles H; Mayles P; Thomas S; Naismith O; Baker A; Mossop H; Cruickshank C; Hall E; Dearnaley D;
    Radiother Oncol; 2020 Jan; 142():62-71. PubMed ID: 31767473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
    Tøndel H; Lund JÅ; Lydersen S; Wanderås AD; Aksnessæther B; Jensen CA; Kaasa S; Solberg A
    Radiother Oncol; 2018 Feb; 126(2):229-235. PubMed ID: 29398152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.